SCHEMBL19029338

SCHEMBL19029338

NC(=O)c1ccc2sc(O)nc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
DYRK1A Q13627 3/20 0.46
LCK P06239 1/20 0.44
HDAC6 Q9UBN7 2/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 1/20 0.43
ATM Q13315 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CA2 P00918 1/20 0.41
KMT2A Q03164 1/20 0.40
GFER P55789 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
ILK Q13418 1/20 0.39
PARP1 P09874 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28247185 0.86 DYRK1A (0.60) NPC1RAB9ASMN1; SMN2DYRK1ALCK
SCHEMBL23480711 0.83 NPC1 (0.54) NPC1RAB9ASMN1; SMN2DYRK1AHDAC6
SCHEMBL9306708 0.81 NPC1 (0.49) NPC1RAB9ASMN1; SMN2DYRK1ALCK
SCHEMBL1748371 0.81 NPC1 (0.49) NPC1RAB9ASMN1; SMN2DYRK1AHDAC6
SCHEMBL24052275 0.81 NPC1 (0.76) NPC1RAB9ASMN1; SMN2DYRK1AALDH1A1
SCHEMBL30874473 0.78 NPC1 (0.45) NPC1RAB9ASMN1; SMN2DYRK1AHDAC6
SCHEMBL8535606 0.75 MAPT (0.68) NPC1RAB9ASMN1; SMN2HDAC6KDM4E
SCHEMBL10760019 0.74 NPC1 (0.48) NPC1RAB9ASMN1; SMN2DYRK1AHDAC6
SCHEMBL28090972 0.74 CA2 (0.56) NPC1RAB9ASMN1; SMN2DYRK1AKDM4E
SCHEMBL7541643 0.73 NPC1 (0.64) NPC1RAB9ASMN1; SMN2DYRK1AHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108602812-A It can be used as the bicycle hydroxamic acid compound of the inhibitor of mammal histone deacetylase activity 坎塞拉有限公司 2018-09-28 CN claimed
EP-3394052-A1 BICYCLIC HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF MAMMALIAN HISTONE DEACETYLASE ACTIVITY Kancera AB (SE) 2018-10-31 EP disclosed
WO-2017108282-A1 BICYCLIC HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF MAMMALIAN HISTONE DEACETYLASE ACTIVITY KANCERA AB (SE) 2017-06-29 WO disclosed